Several psychedelic and psychedelic-adjacent therapies are advancing through late-stage clinical development, expanding the evidence base supporting their efficacy in the management of anxiety and depressive disorders. However, many clinicians remain unfamiliar with how these therapeutic models differ from conventional treatments and are uncertain about when these treatments may be appropriate for individual patients. In this CE podcast, expert faculty will distinguish emerging psychedelic therapies from currently available treatment options and outline practical, evidence-based approaches for integrating these therapies into routine care for patients with anxiety or depression.   To claim CE credit after listening to this episode, go to this link and check the "Already listened on another platform?" box: https://www.healio.com/cme/mededtalks/psychiatry/20260430/psychedelics-in-anxiety-and-depression

In this podcast, expert clinicians will discuss the management of bipolar depression during and after the COVID-19 pandemic.

In this podcast, expert clinicians will discuss the adverse event profiles associated with bipolar medications.

In this podcast, expert clinicians will discuss the latest data on both available and emerging agents used to treat bipolar depression.

In this podcast, expert clinicians will discuss the mechanisms of action of available and emerging agents used to treat bipolar depression.